Artificial narrow intelligence (ANI) will most likely help healthcare move from traditional, „one-size-fits-all” medical solutions towards targeted treatments, personalized therapies, and uniquely composed drugs. In two words: precision medicine. However, before we let ANI take over the stage in healthcare, stakeholders should consider several ethical and legal issues.
Some say technology will replace 80% of doctors in the future. I disagree. Instead, technology will finally allow doctors to focus on what makes them good physicians: treating patients and innovating, while automation does the repetitive part of the work. While every specialty will benefit from digital health, some will especially thrive due to these innovations. Here, we enlisted the medical fields with the biggest potential for development in the future.
From portable genome sequencers until genetic tests revealing distant relations with Thomas Jefferson, genomics represents a fascinatingly innovative area of healthcare. As the price of genome sequencing has been in free fall for years, the start-up scene is bursting from transformative power. Let’s look at some of the most amazing ventures in genomics!
In the fight against cancer, precision medicine is one of the most promising tools and the logical outcome of current healthcare trends. As start-ups offering personalized healthcare solutions multiply like mushrooms after rain, governments and regulatory agencies have to give appropriate responses in regulating the grass-root healthcare jungle. Here is my analysis about the potential and dilemmas about precision medicine.
Genome sequencing does definitely not equal with fortune telling: it cannot predict how long you will live or what your body mass index will look like. However, it can tell you a lot about your sensitivity to drugs, your family history or whether you are a carrier of monogenic conditions.
I was offered a genetic test by MyDNA that promises to let you know how your body metabolizes medications based on your genetic background. It might be crucial in the future when deciding about certain drugs for certain diseases. Here, I show you the results of my review.
“We don’t want to miss the train of digital health” is a phrase I often hear from pharmaceutical companies. However, there are no trains to catch anymore. Disruptive healthcare trends are the futuristic spaceships many pharma companies don’t even see flying above them. If pharma doesn’t prepare for the coming waves of change, it won’t have an industry at all.